Clinical Trial: Efficacy and Safety of Intravesical TARA-002 Compared With Investigator's Choice of Intravesical Chemotherapy in Participants With BCG-naive High-grade Non-muscle Invasive Bladder Cancer

U.S., March 19 -- ClinicalTrials.gov registry received information related to the study (NCT07480356) titled 'Efficacy and Safety of Intravesical TARA-002 Compared With Investigator's Choice of Intravesical Chemotherapy in Participants With BCG-naive High-grade Non-muscle Invasive Bladder Cancer' on March 13.

Brief Summary: The goal of this clinical trial is to learn if TARA-002 can treat high-grade non-muscle invasive bladder cancer (NMIBC) in BCG-naive adults 18 years of age or older.

The main questions it aims to answer are:

* Can the study drug help participants with this type of cancer?

* Is the study drug safe?

* What are the side effects of the study drug?

Researchers will compare TARA-002 to chemotherapy to see if TARA-002 wor...